In human triple-negative breast cancer, inhibition of BAZ2A has been demonstrated to induce apoptosis, while BAZ2A has also been implicated in regulating hypermethylation, contributing to advanced tumor stages and recurrence in prostate cancer [34]. This evidence concerns the gene BAZ2A and prostate carcinoma.